Unknown

Dataset Information

Serum prognostic biomarkers in head and neck cancer patients.


ABSTRACT:

Objectives/hypothesis

A reliable estimate of survival is important as it may impact treatment choice. The objective of this study is to identify serum autoantibody biomarkers that can be used to improve prognostication for patients affected with head and neck squamous cell carcinoma (HNSCC).

Study design

Prospective cohort study.

Methods

A panel of 130 serum biomarkers, previously selected for cancer detection using microarray-based serological profiling and specialized bioinformatics, were evaluated for their potential as prognostic biomarkers in a cohort of 119 HNSCC patients followed for up to 12.7 years. A biomarker was considered positive if its reactivity to the particular patient's serum was greater than one standard deviation above the mean reactivity to sera

SUBMITTER: Lin HS 

PROVIDER: S-EPMC4129948 | biostudies-literature | 2014 Aug

REPOSITORIES: biostudies-literature